550098128	550098128	CD	B-NP	O
|	|	NN	I-NP	O
PTHKMC	PTHKMC	NN	I-NP	O
|	|	NN	I-NP	O
18918213	18918213	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5889230	5889230	CD	B-NP	O
|	|	CC	I-NP	O
8/16/2004	8/16/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2004	10/10/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/8/2004	10/8/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
TABIOS	TABIOS	NN	I-NP	O
,	,	,	O	O
MARLIN	MARLIN	NNP	B-NP	O
043-91-24-4	043-91-24-4	CD	I-NP	O
Road	Road	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/16/04	4/16/04	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BOYSEN	BOYSEN	NN	B-NP	O
,	,	,	O	O
ANDREA	ANDREA	NNP	B-NP	O
JORDAN	JORDAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ATENOLOL	ATENOLOL	NN	B-NP	O
100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
REGLAN	REGLAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
warm	warm	JJ	B-NP	O
water	water	NN	I-NP	O
,	,	,	O	O
separately	separately	RB	B-ADVP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
pills	pill	NNS	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

Thanks	Thank	NNS	B-NP	O
,	,	,	O	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3.75	3.75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/26	10/26	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/21/04	2/21/04	CD	B-NP	O
by	by	IN	B-PP	O
ROMANI	ROMANI	NNP	B-NP	O
,	,	,	O	O
LONG	LONG	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/21/04	2/21/04	CD	B-NP	O
by	by	IN	B-PP	O
STUBBE	STUBBE	NN	B-NP	O
,	,	,	O	O
SAMMIE	SAMMIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
29824931	29824931	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/11/04	4/11/04	CD	B-NP	O
by	by	IN	B-PP	O
SISEMORE	SISEMORE	NNP	B-NP	O
,	,	,	O	O
AL	AL	NNP	B-NP	O
MANUAL	MANUAL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
INSULIN	INSULIN	NNP	B-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
HUMAN	HUMAN	NN	I-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
;	;	:	O	I-DNA
0	0	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
0	0	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	O
COZAAR	COZAAR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
PROTONIX	PROTONIX	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
asselmeier	asselmei	JJR	B-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/27/04	6/27/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
keiffer	keiffer	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
idiopathic	idiopathic	JJ	I-NP	O
dilated	dilated	JJ	I-NP	O
CM	CM	NN	I-NP	O
hx	hx	NN	I-NP	O
asthma	asthma	NN	I-NP	O
hx	hx	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Nephrotic	Nephrotic	JJ	I-NP	O
Syndrome	Syndrome	NN	I-NP	O
2/2	2/2	CD	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
AICD	AICD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
h/o	h/o	NN	B-NP	O
VT	VT	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
56F	56F	NN	B-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
.	.	.	O	O

of	of	IN	B-PP	O
idiopathic	idiopathic	JJ	B-NP	B-protein
cmp	cmp	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ef	ef	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extermity	extermity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
reports	report	NNS	B-NP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
lower	low	JJR	B-NP	O
extermity	extermity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
been	be	VBN	B-VP	O
taking	take	VBG	I-VP	O
all	all	DT	B-NP	O
meds	med	NNS	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
had	have	VBD	I-VP	O
multiple	multiple	JJ	B-NP	O
dietary	dietary	JJ	I-NP	O
indiscretions	indiscretion	NNS	I-NP	O
including	include	VBG	B-PP	O
chicken	chicken	NN	B-NP	B-protein
noodle	noodle	NN	I-NP	I-protein
soup	soup	NN	I-NP	I-protein
and	and	CC	O	O
grilled	grilled	JJ	B-NP	O
ham	ham	NN	I-NP	O
cheese	cheese	NN	I-NP	O
sandwich	sandwich	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
discontinues	discontinue	VBZ	B-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
with	with	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
emergency	emergency	NN	B-NP	O
department	department	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
/	/	SYM	I-NP	O
138/87	138/87	CD	I-NP	O
/	/	SYM	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
mod	mod	NN	B-NP	O
.	.	.	O	O

pulm	pulm	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
small	small	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	I-NP	O
LLL	LLL	NN	I-NP	O
opacity	opacity	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
jvp	jvp	NN	B-NP	O
10	10	CD	I-NP	O
chest	chest	NN	I-NP	O
:	:	:	O	O
crackles	crackle	NNS	B-NP	O
1/4	1/4	CD	B-NP	O
bases	base	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
cv	cv	NN	I-NP	O
:	:	:	O	O
enlarged	enlarge	VBN	B-NP	O
pmi	pmi	NN	I-NP	O
,	,	,	O	O
rv	rv	NN	B-NP	O
heave	heave	NN	I-NP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
hsm	hsm	NN	I-NP	O
lsb	lsb	NN	I-NP	O
,	,	,	O	O
apex	apex	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
gallops	gallop	NNS	I-NP	O
abd	abd	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
organomegaly	organomegaly	NN	I-NP	O
;	;	:	O	O
ext	ext	NN	B-NP	O
:	:	:	O	O
warm	warm	NN	B-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
,	,	,	O	O
Asthma	Asthma	NN	B-NP	O
,	,	,	O	O
cva/brain	cva/brain	NN	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
AICD	AICD	NN	B-NP	O
for	for	IN	B-PP	O
VT	VT	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
dvt	dvt	NN	B-NP	O
R.leg	R.leg	NNP	I-NP	O
,	,	,	O	O
gerd	gerd	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
Hypertension	Hypertension	NNP	B-NP	O
SH	SH	NNP	I-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
with	with	IN	B-PP	O
son	son	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
cig/day	cig/day	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
etoh	etoh	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
nsr	nsr	NN	B-NP	O
nl	nl	NN	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
qtc	qtc	NN	B-NP	B-protein
473	473	CD	B-NP	I-protein
lae	lae	NNS	I-NP	I-protein
,	,	,	O	O
lvh	lvh	NN	B-NP	O
,	,	,	O	O
lat	lat	JJ	B-NP	O
twi	twi	NNS	I-NP	O
,	,	,	O	O
st	st	NN	B-NP	O
elev	elev	NN	I-NP	O
,	,	,	O	O
v1	v1	NN	B-NP	O
,	,	,	O	O
v2	v2	NN	B-NP	B-protein
--	--	:	O	I-protein
old	old	JJ	B-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
bnp	bnp	NN	B-NP	O
:	:	:	O	O
3726	3726	CD	B-NP	O
ck	ck	NN	I-NP	O
937	937	CD	B-NP	O
mb	mb	NN	I-NP	O
7.3	7.3	CD	B-NP	O
tn	tn	NN	I-NP	O
<	<	SYM	B-NP	O
assay	assay	NN	I-NP	O
echo	echo	NN	I-NP	O
:	:	:	O	O
ECHO	ECHO	NN	B-NP	O
:	:	:	O	O
10/14/03	10/14/03	CD	B-NP	O
severe	severe	JJ	I-NP	O
global	global	JJ	I-NP	O
lvhk	lvhk	NN	I-NP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
lae	lae	NNS	I-NP	O
,	,	,	O	O
decraesed	decraese	VBD	B-VP	O
rv	rv	NN	B-NP	B-protein
f	f	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
x	x	SYM	B-VP	I-protein
-RRB-	-RRB-	NN	B-NP	I-protein
,	,	,	O	O
MR	MR	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
tr	tr	NN	I-NP	O
,	,	,	O	O
pasp	pasp	NN	B-NP	O
28	28	CD	I-NP	O
Assessment	Assessment	NN	I-NP	O
56	56	CD	B-NP	O
female	female	JJ	I-NP	O
idiopathic	idiopathic	JJ	I-NP	O
CMP	CMP	NN	I-NP	O
.	.	.	O	O

Presents	Present	NNS	B-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
exacerbation	exacerbation	NN	I-NP	I-protein
2/2	2/2	CD	I-NP	I-protein
dietary	dietary	JJ	I-NP	I-protein
indiscretion	indiscretion	NN	I-NP	I-protein
*************************	*************************	SYM	B-VP	I-protein
Hospital	Hospital	NN	B-NP	I-protein
Course	Course	NN	I-NP	I-protein
********************	********************	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
ISCH	ISCH	NN	I-NP	O
:	:	:	O	O
Elevated	Elevate	VBN	B-NP	O
ck	ck	NN	I-NP	O
,	,	,	O	O
tni	tni	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	B-VP	I-protein
-	-	HYPH	O	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
ckmb	ckmb	NN	B-NP	O
low	low	JJ	I-NP	O
,	,	,	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
X3	X3	NN	B-NP	O
cont	cont	NN	I-NP	O
.	.	.	O	O

Beta	Beta	NNP	B-NP	O
Blocker	Blocker	NNP	I-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
non-occlusive	non-occlusive	JJ	B-NP	O
2vd	2vd	NN	I-NP	O
on	on	IN	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
warm	warm	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
wet	wet	JJ	I-ADJP	O
;	;	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diresed	direse	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
Liters	Liter	NNS	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
149	149	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
of	of	IN	B-PP	O
3700	3700	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
house	house	NN	B-NP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
Cozaar	Cozaar	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

Beta	Beta	NNP	B-NP	O
Blocker	Blocker	NNP	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-VP	O
once	once	VB	I-VP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
8/28	8/28	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	B-protein
21	21	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
mV	mV	NN	I-NP	I-protein
moderate	moderate	JJ	I-NP	I-protein
mr	mr	NN	I-NP	I-protein
,	,	,	O	O
incomplete	incomplete	JJ	B-NP	O
closure	closure	NN	I-NP	O
,	,	,	O	O
TV	TV	NN	B-NP	O
:	:	:	O	O
moderate	moderate	JJ	B-NP	O
tr	tr	NN	I-NP	O
,	,	,	O	O
incomplete	incomplete	JJ	B-NP	O
closure	closure	NN	I-NP	O
;	;	:	O	O
LV	LV	NN	B-NP	B-protein
globak	globak	NN	I-NP	I-protein
HK	HK	NN	I-NP	I-protein
,	,	,	O	O
rv	rv	NN	B-NP	O
mildly	mildly	RB	B-ADVP	O
to	to	TO	B-VP	O
moderately	moderately	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
,	,	,	O	O
incomplete	incomplete	JJ	B-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
not	not	RB	B-VP	O
fully	fully	RB	I-VP	O
cooperating	cooperate	VBG	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
final	final	JJ	B-NP	O
day	day	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
symptomatic	symptomatic	JJ	B-NP	O
dehydra	dehydra	NN	I-NP	O
tion	tion	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
orthostatic	orthostatic	JJ	B-ADJP	O
-	-	HYPH	O	O
symptoms	symptom	NNS	B-NP	O
resoved	resove	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
500	500	CD	I-NP	O
cc	cc	NN	I-NP	O
NS	NS	NN	I-NP	O
bolus	bolus	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
regiment	regiment	NN	I-NP	O
was	be	VBD	B-VP	O
modified	modify	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
dc	dc	NN	B-NP	O
'd	'd	NN	I-NP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
10	10	CD	I-NP	I-protein
am	am	NN	I-NP	I-protein
.	.	.	O	O

THe	THe	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
regimine	regimine	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
40	40	CD	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
was	be	VBD	B-VP	O
causing	cause	VBG	I-VP	O
both	both	CC	O	O
hyper	hyper	NN	B-NP	O
and	and	CC	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
down	down	JJ	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
AM	AM	NN	I-NP	I-protein
and	and	CC	I-NP	O
PM	PM	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

THe	THe	NN	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
extremely	extremely	RB	B-ADJP	O
hypoglycmeic	hypoglycmeic	JJ	I-ADJP	O
on	on	IN	B-PP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
70/30	70/30	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PM	PM	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
PM	PM	NN	I-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
being	be	VBG	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diet	diet	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
higher	high	JJR	B-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	I-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
content	content	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Fs	F	NNS	I-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
further	further	JJ	B-NP	O
w/up	w/up	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
reccomend	reccomend	VBP	B-VP	O
titrating	titrate	VBG	I-VP	O
the	the	DT	B-NP	O
70/30	70/30	CD	I-NP	O
insulin	insulin	NN	I-NP	O
up	up	RP	B-PRT	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
epigastric	epigastric	JJ	I-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
said	say	VBD	B-VP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
represents	represent	VBZ	B-VP	O
diabetic	diabetic	JJ	B-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
reglan	reglan	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
PO	PO	NNP	B-NP	O
's	's	POS	B-NP	O
better	good	JJR	I-NP	O
subsequently	subsequently	RB	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
symptomatic	symptomatic	JJ	I-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
cont	cont	VB	B-VP	O
coumadin	coumadin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

PROPHYLAXIS	PROPHYLAXIS	NN	B-NP	O
:	:	:	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
full	full	JJ	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	NN	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Scarles	Scarles	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
switch	switch	VB	I-VP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
to	to	TO	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
70/30	70/30	CD	B-NP	O
insulin	insulin	NN	I-NP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
may	may	MD	B-VP	O
make	make	VB	I-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
regimin	regimin	NN	I-NP	I-protein
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	B-cell_type
recorded	record	VBN	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
sugars	sugar	NNS	I-NP	I-cell_type
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
stop	stop	VB	I-VP	O
taking	take	VBG	I-VP	O
Metoprolol	Metoprolol	NNP	B-NP	O
and	and	CC	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
start	start	VB	I-VP	O
taking	take	VBG	I-VP	O
Cozaar	Cozaar	NNP	B-NP	O
and	and	CC	I-NP	O
Atenolol	Atenolol	NNP	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
Reglan	Reglan	NN	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
management	management	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
management	management	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
medical	medical	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WOHLWENDI	WOHLWENDI	NNP	B-NP	O
,	,	,	O	O
BARRETT	BARRETT	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RC80	RC80	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/16/04	4/16/04	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

